nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—ABCB1—Lisinopril—dilated cardiomyopathy	0.0929	0.532	CbGbCtD
Maprotiline—ABCB1—Spironolactone—dilated cardiomyopathy	0.0818	0.468	CbGbCtD
Maprotiline—Drug fever—Spironolactone—dilated cardiomyopathy	0.0301	0.0632	CcSEcCtD
Maprotiline—Depressive symptom—Lisinopril—dilated cardiomyopathy	0.0188	0.0395	CcSEcCtD
Maprotiline—Indecainide—SCN5A—dilated cardiomyopathy	0.0185	0.804	CrCbGaD
Maprotiline—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.0155	0.0325	CcSEcCtD
Maprotiline—SLC6A2—sympathetic nervous system—dilated cardiomyopathy	0.0149	0.216	CbGeAlD
Maprotiline—HTR7—pulmonary artery—dilated cardiomyopathy	0.0147	0.214	CbGeAlD
Maprotiline—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.0143	0.208	CbGeAlD
Maprotiline—HTR2A—pulmonary artery—dilated cardiomyopathy	0.00919	0.134	CbGeAlD
Maprotiline—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00898	0.0189	CcSEcCtD
Maprotiline—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.00893	0.13	CbGeAlD
Maprotiline—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00731	0.0154	CcSEcCtD
Maprotiline—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00705	0.0148	CcSEcCtD
Maprotiline—Ataxia—Spironolactone—dilated cardiomyopathy	0.00685	0.0144	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00656	0.0138	CcSEcCtD
Maprotiline—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00624	0.0131	CcSEcCtD
Maprotiline—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00607	0.0128	CcSEcCtD
Maprotiline—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0058	0.0122	CcSEcCtD
Maprotiline—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00562	0.0118	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00557	0.0117	CcSEcCtD
Maprotiline—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00535	0.0112	CcSEcCtD
Maprotiline—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00524	0.011	CcSEcCtD
Maprotiline—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00522	0.011	CcSEcCtD
Maprotiline—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00494	0.0104	CcSEcCtD
Maprotiline—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00477	0.01	CcSEcCtD
Maprotiline—Alopecia—Spironolactone—dilated cardiomyopathy	0.00446	0.00936	CcSEcCtD
Maprotiline—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00443	0.00932	CcSEcCtD
Maprotiline—Purpura—Furosemide—dilated cardiomyopathy	0.00411	0.00865	CcSEcCtD
Maprotiline—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.0041	0.00862	CcSEcCtD
Maprotiline—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00398	0.00837	CcSEcCtD
Maprotiline—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00393	0.00826	CcSEcCtD
Maprotiline—Urinary retention—Furosemide—dilated cardiomyopathy	0.00377	0.00792	CcSEcCtD
Maprotiline—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00362	0.00761	CcSEcCtD
Maprotiline—Confusional state—Spironolactone—dilated cardiomyopathy	0.00361	0.00759	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00357	0.00751	CcSEcCtD
Maprotiline—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00351	0.00737	CcSEcCtD
Maprotiline—Muscular weakness—Furosemide—dilated cardiomyopathy	0.0035	0.00735	CcSEcCtD
Maprotiline—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00344	0.00722	CcSEcCtD
Maprotiline—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00339	0.00713	CcSEcCtD
Maprotiline—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00327	0.00686	CcSEcCtD
Maprotiline—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00321	0.00674	CcSEcCtD
Maprotiline—Somnolence—Spironolactone—dilated cardiomyopathy	0.00318	0.00669	CcSEcCtD
Maprotiline—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00317	0.00665	CcSEcCtD
Maprotiline—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00313	0.00658	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00309	0.0065	CcSEcCtD
Maprotiline—Drowsiness—Furosemide—dilated cardiomyopathy	0.00306	0.00642	CcSEcCtD
Maprotiline—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00304	0.00638	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00303	0.00637	CcSEcCtD
Maprotiline—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00298	0.00625	CcSEcCtD
Maprotiline—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00295	0.0062	CcSEcCtD
Maprotiline—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00295	0.0062	CcSEcCtD
Maprotiline—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00289	0.00607	CcSEcCtD
Maprotiline—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00285	0.00599	CcSEcCtD
Maprotiline—Urticaria—Spironolactone—dilated cardiomyopathy	0.00285	0.00598	CcSEcCtD
Maprotiline—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00283	0.00595	CcSEcCtD
Maprotiline—Ataxia—Lisinopril—dilated cardiomyopathy	0.0028	0.00588	CcSEcCtD
Maprotiline—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00272	0.00571	CcSEcCtD
Maprotiline—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00271	0.00569	CcSEcCtD
Maprotiline—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00269	0.00565	CcSEcCtD
Maprotiline—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00269	0.00565	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00268	0.00563	CcSEcCtD
Maprotiline—CHRM2—heart—dilated cardiomyopathy	0.00259	0.0377	CbGeAlD
Maprotiline—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00259	0.00545	CcSEcCtD
Maprotiline—Eye disorder—Furosemide—dilated cardiomyopathy	0.00256	0.00539	CcSEcCtD
Maprotiline—Tinnitus—Furosemide—dilated cardiomyopathy	0.00256	0.00538	CcSEcCtD
Maprotiline—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00255	0.00535	CcSEcCtD
Maprotiline—Pruritus—Spironolactone—dilated cardiomyopathy	0.00253	0.00533	CcSEcCtD
Maprotiline—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00253	0.00532	CcSEcCtD
Maprotiline—Sweating increased—Lisinopril—dilated cardiomyopathy	0.0025	0.00526	CcSEcCtD
Maprotiline—Angiopathy—Furosemide—dilated cardiomyopathy	0.00249	0.00523	CcSEcCtD
Maprotiline—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00245	0.00515	CcSEcCtD
Maprotiline—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00245	0.00515	CcSEcCtD
Maprotiline—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00244	0.00513	CcSEcCtD
Maprotiline—Malnutrition—Furosemide—dilated cardiomyopathy	0.00239	0.00502	CcSEcCtD
Maprotiline—Dizziness—Spironolactone—dilated cardiomyopathy	0.00237	0.00498	CcSEcCtD
Maprotiline—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00237	0.00498	CcSEcCtD
Maprotiline—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00235	0.00493	CcSEcCtD
Maprotiline—Weight increased—Lisinopril—dilated cardiomyopathy	0.00234	0.00492	CcSEcCtD
Maprotiline—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00234	0.00492	CcSEcCtD
Maprotiline—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00233	0.00489	CcSEcCtD
Maprotiline—Vomiting—Spironolactone—dilated cardiomyopathy	0.00228	0.00479	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00227	0.00478	CcSEcCtD
Maprotiline—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00226	0.00475	CcSEcCtD
Maprotiline—Rash—Spironolactone—dilated cardiomyopathy	0.00226	0.00475	CcSEcCtD
Maprotiline—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00226	0.00474	CcSEcCtD
Maprotiline—Vision blurred—Furosemide—dilated cardiomyopathy	0.00225	0.00473	CcSEcCtD
Maprotiline—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00225	0.00472	CcSEcCtD
Maprotiline—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00225	0.00472	CcSEcCtD
Maprotiline—Headache—Spironolactone—dilated cardiomyopathy	0.00224	0.00472	CcSEcCtD
Maprotiline—Jaundice—Lisinopril—dilated cardiomyopathy	0.00223	0.0047	CcSEcCtD
Maprotiline—Agitation—Furosemide—dilated cardiomyopathy	0.00219	0.00461	CcSEcCtD
Maprotiline—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00217	0.00456	CcSEcCtD
Maprotiline—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00214	0.0045	CcSEcCtD
Maprotiline—Leukopenia—Furosemide—dilated cardiomyopathy	0.00214	0.00449	CcSEcCtD
Maprotiline—Nausea—Spironolactone—dilated cardiomyopathy	0.00213	0.00447	CcSEcCtD
Maprotiline—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00206	0.00433	CcSEcCtD
Maprotiline—Hallucination—Lisinopril—dilated cardiomyopathy	0.00205	0.0043	CcSEcCtD
Maprotiline—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00203	0.00427	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00202	0.00424	CcSEcCtD
Maprotiline—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00202	0.00424	CcSEcCtD
Maprotiline—HTR7—heart—dilated cardiomyopathy	0.00201	0.0293	CbGeAlD
Maprotiline—Desipramine—SLC22A5—dilated cardiomyopathy	0.00199	0.0864	CrCbGaD
Maprotiline—Dry mouth—Furosemide—dilated cardiomyopathy	0.00199	0.00418	CcSEcCtD
Maprotiline—Confusional state—Furosemide—dilated cardiomyopathy	0.00196	0.00413	CcSEcCtD
Maprotiline—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00195	0.00409	CcSEcCtD
Maprotiline—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00192	0.00403	CcSEcCtD
Maprotiline—Shock—Furosemide—dilated cardiomyopathy	0.00192	0.00403	CcSEcCtD
Maprotiline—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00191	0.00402	CcSEcCtD
Maprotiline—Flushing—Lisinopril—dilated cardiomyopathy	0.00191	0.00401	CcSEcCtD
Maprotiline—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00191	0.00401	CcSEcCtD
Maprotiline—Skin disorder—Furosemide—dilated cardiomyopathy	0.00189	0.00398	CcSEcCtD
Maprotiline—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00188	0.00396	CcSEcCtD
Maprotiline—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00187	0.00392	CcSEcCtD
Maprotiline—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00185	0.0039	CcSEcCtD
Maprotiline—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00184	0.00386	CcSEcCtD
Maprotiline—Hypotension—Furosemide—dilated cardiomyopathy	0.00182	0.00383	CcSEcCtD
Maprotiline—Alopecia—Lisinopril—dilated cardiomyopathy	0.00182	0.00382	CcSEcCtD
Maprotiline—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00179	0.00377	CcSEcCtD
Maprotiline—Tension—Lisinopril—dilated cardiomyopathy	0.00176	0.0037	CcSEcCtD
Maprotiline—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00175	0.00369	CcSEcCtD
Maprotiline—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00175	0.00368	CcSEcCtD
Maprotiline—Nervousness—Lisinopril—dilated cardiomyopathy	0.00174	0.00366	CcSEcCtD
Maprotiline—Somnolence—Furosemide—dilated cardiomyopathy	0.00173	0.00364	CcSEcCtD
Maprotiline—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00169	0.00355	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00168	0.00354	CcSEcCtD
Maprotiline—Fatigue—Furosemide—dilated cardiomyopathy	0.00168	0.00353	CcSEcCtD
Maprotiline—Tremor—Lisinopril—dilated cardiomyopathy	0.00168	0.00353	CcSEcCtD
Maprotiline—Constipation—Furosemide—dilated cardiomyopathy	0.00167	0.0035	CcSEcCtD
Maprotiline—Syncope—Lisinopril—dilated cardiomyopathy	0.00161	0.00338	CcSEcCtD
Maprotiline—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00161	0.00338	CcSEcCtD
Maprotiline—Leukopenia—Lisinopril—dilated cardiomyopathy	0.0016	0.00337	CcSEcCtD
Maprotiline—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00159	0.00335	CcSEcCtD
Maprotiline—Palpitations—Lisinopril—dilated cardiomyopathy	0.00158	0.00333	CcSEcCtD
Maprotiline—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00157	0.00331	CcSEcCtD
Maprotiline—Urticaria—Furosemide—dilated cardiomyopathy	0.00155	0.00325	CcSEcCtD
Maprotiline—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00154	0.00324	CcSEcCtD
Maprotiline—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00154	0.00324	CcSEcCtD
Maprotiline—Anxiety—Lisinopril—dilated cardiomyopathy	0.00152	0.0032	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00151	0.00318	CcSEcCtD
Maprotiline—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00149	0.00314	CcSEcCtD
Maprotiline—Confusional state—Lisinopril—dilated cardiomyopathy	0.00147	0.0031	CcSEcCtD
Maprotiline—Oedema—Lisinopril—dilated cardiomyopathy	0.00146	0.00307	CcSEcCtD
Maprotiline—Infection—Lisinopril—dilated cardiomyopathy	0.00145	0.00305	CcSEcCtD
Maprotiline—Shock—Lisinopril—dilated cardiomyopathy	0.00144	0.00302	CcSEcCtD
Maprotiline—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00143	0.00301	CcSEcCtD
Maprotiline—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00143	0.003	CcSEcCtD
Maprotiline—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00142	0.00299	CcSEcCtD
Maprotiline—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00141	0.00297	CcSEcCtD
Maprotiline—Asthenia—Furosemide—dilated cardiomyopathy	0.0014	0.00294	CcSEcCtD
Maprotiline—Pruritus—Furosemide—dilated cardiomyopathy	0.00138	0.0029	CcSEcCtD
Maprotiline—Desipramine—ADRB1—dilated cardiomyopathy	0.00138	0.0597	CrCbGaD
Maprotiline—Hypotension—Lisinopril—dilated cardiomyopathy	0.00137	0.00287	CcSEcCtD
Maprotiline—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00133	0.0028	CcSEcCtD
Maprotiline—Insomnia—Lisinopril—dilated cardiomyopathy	0.00132	0.00278	CcSEcCtD
Maprotiline—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00131	0.00276	CcSEcCtD
Maprotiline—Somnolence—Lisinopril—dilated cardiomyopathy	0.0013	0.00273	CcSEcCtD
Maprotiline—Dizziness—Furosemide—dilated cardiomyopathy	0.00129	0.00271	CcSEcCtD
Maprotiline—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00129	0.00271	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00126	0.00265	CcSEcCtD
Maprotiline—Fatigue—Lisinopril—dilated cardiomyopathy	0.00126	0.00265	CcSEcCtD
Maprotiline—HTR2A—heart—dilated cardiomyopathy	0.00125	0.0182	CbGeAlD
Maprotiline—Constipation—Lisinopril—dilated cardiomyopathy	0.00125	0.00263	CcSEcCtD
Maprotiline—Vomiting—Furosemide—dilated cardiomyopathy	0.00124	0.0026	CcSEcCtD
Maprotiline—Rash—Furosemide—dilated cardiomyopathy	0.00123	0.00258	CcSEcCtD
Maprotiline—Dermatitis—Furosemide—dilated cardiomyopathy	0.00123	0.00258	CcSEcCtD
Maprotiline—Headache—Furosemide—dilated cardiomyopathy	0.00122	0.00257	CcSEcCtD
Maprotiline—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.0012	0.00253	CcSEcCtD
Maprotiline—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.0012	0.00251	CcSEcCtD
Maprotiline—Urticaria—Lisinopril—dilated cardiomyopathy	0.00116	0.00244	CcSEcCtD
Maprotiline—Desipramine—ADRB2—dilated cardiomyopathy	0.00116	0.0502	CrCbGaD
Maprotiline—Nausea—Furosemide—dilated cardiomyopathy	0.00116	0.00243	CcSEcCtD
Maprotiline—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00116	0.00243	CcSEcCtD
Maprotiline—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00116	0.00243	CcSEcCtD
Maprotiline—Asthenia—Lisinopril—dilated cardiomyopathy	0.00105	0.00221	CcSEcCtD
Maprotiline—Pruritus—Lisinopril—dilated cardiomyopathy	0.00103	0.00217	CcSEcCtD
Maprotiline—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.001	0.0021	CcSEcCtD
Maprotiline—Dizziness—Lisinopril—dilated cardiomyopathy	0.000967	0.00203	CcSEcCtD
Maprotiline—Vomiting—Lisinopril—dilated cardiomyopathy	0.00093	0.00195	CcSEcCtD
Maprotiline—Rash—Lisinopril—dilated cardiomyopathy	0.000922	0.00194	CcSEcCtD
Maprotiline—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000921	0.00194	CcSEcCtD
Maprotiline—Headache—Lisinopril—dilated cardiomyopathy	0.000916	0.00193	CcSEcCtD
Maprotiline—Nausea—Lisinopril—dilated cardiomyopathy	0.000869	0.00183	CcSEcCtD
Maprotiline—ABCB1—heart—dilated cardiomyopathy	0.000822	0.012	CbGeAlD
Maprotiline—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000121	0.00047	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000121	0.00047	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00012	0.000467	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00012	0.000466	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00012	0.000466	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.000117	0.000455	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000117	0.000453	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000117	0.000452	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000116	0.00045	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000115	0.000445	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000115	0.000445	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000114	0.000444	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000114	0.000443	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000114	0.000442	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000114	0.000441	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000114	0.000441	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000114	0.000441	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000113	0.00044	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000113	0.000438	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000113	0.000437	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000111	0.000431	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000111	0.00043	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000111	0.000429	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00011	0.000428	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00011	0.000427	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.00011	0.000426	CbGpPWpGaD
Maprotiline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00011	0.000426	CbGpPWpGaD
Maprotiline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00011	0.000425	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000109	0.000424	CbGpPWpGaD
Maprotiline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000109	0.000423	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000109	0.000423	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000109	0.000423	CbGpPWpGaD
Maprotiline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000109	0.000422	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000109	0.000421	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000108	0.000421	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000108	0.000417	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000108	0.000417	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000106	0.000412	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000106	0.00041	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000104	0.000405	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000104	0.000404	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000104	0.000404	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000104	0.000403	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000104	0.000403	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000104	0.000402	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000104	0.000402	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000103	0.0004	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000103	0.000399	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000103	0.000399	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000103	0.000398	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000102	0.000397	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000101	0.000391	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.99e-05	0.000388	CbGpPWpGaD
Maprotiline—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.98e-05	0.000387	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	9.94e-05	0.000386	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.91e-05	0.000384	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.89e-05	0.000383	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.87e-05	0.000383	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.86e-05	0.000382	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—AGT—dilated cardiomyopathy	9.85e-05	0.000382	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.83e-05	0.000381	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.73e-05	0.000377	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.68e-05	0.000375	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.64e-05	0.000374	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.57e-05	0.000371	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.49e-05	0.000368	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.47e-05	0.000367	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.45e-05	0.000367	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.44e-05	0.000366	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—AGT—dilated cardiomyopathy	9.43e-05	0.000366	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.41e-05	0.000365	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.31e-05	0.000361	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.27e-05	0.000359	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.15e-05	0.000355	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9e-05	0.000349	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.98e-05	0.000348	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.95e-05	0.000347	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.92e-05	0.000346	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.86e-05	0.000344	CbGpPWpGaD
Maprotiline—SLC6A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.84e-05	0.000343	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.84e-05	0.000343	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.75e-05	0.000339	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.47e-05	0.000328	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.39e-05	0.000325	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.39e-05	0.000325	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.34e-05	0.000323	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.3e-05	0.000322	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.27e-05	0.000321	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.21e-05	0.000318	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.19e-05	0.000318	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.16e-05	0.000317	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.14e-05	0.000316	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.06e-05	0.000313	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.05e-05	0.000312	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.92e-05	0.000307	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.84e-05	0.000304	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.82e-05	0.000303	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.8e-05	0.000303	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.69e-05	0.000298	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	7.69e-05	0.000298	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.68e-05	0.000298	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.65e-05	0.000297	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.63e-05	0.000296	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	7.59e-05	0.000294	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.56e-05	0.000293	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.55e-05	0.000293	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.51e-05	0.000291	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.47e-05	0.00029	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.41e-05	0.000287	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.41e-05	0.000287	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.35e-05	0.000285	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.34e-05	0.000284	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.31e-05	0.000284	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.29e-05	0.000283	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.29e-05	0.000283	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.29e-05	0.000283	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.27e-05	0.000282	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.27e-05	0.000282	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.25e-05	0.000281	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.25e-05	0.000281	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.24e-05	0.000281	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	7.23e-05	0.00028	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.23e-05	0.00028	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.23e-05	0.00028	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.22e-05	0.00028	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.16e-05	0.000277	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.16e-05	0.000277	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.14e-05	0.000277	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.1e-05	0.000275	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.99e-05	0.000271	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.97e-05	0.00027	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.95e-05	0.000269	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.93e-05	0.000269	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.89e-05	0.000267	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.86e-05	0.000266	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.83e-05	0.000265	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	6.78e-05	0.000263	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.78e-05	0.000263	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.76e-05	0.000262	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.74e-05	0.000261	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.74e-05	0.000261	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.72e-05	0.00026	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	6.68e-05	0.000259	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.67e-05	0.000259	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	6.66e-05	0.000258	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.65e-05	0.000258	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	6.64e-05	0.000257	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	6.62e-05	0.000257	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.56e-05	0.000254	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	6.55e-05	0.000254	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.55e-05	0.000254	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.54e-05	0.000254	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.53e-05	0.000253	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.51e-05	0.000252	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.45e-05	0.00025	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.45e-05	0.00025	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	6.45e-05	0.00025	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.44e-05	0.00025	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	6.16e-05	0.000239	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.12e-05	0.000237	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—RAC1—dilated cardiomyopathy	6.09e-05	0.000236	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.07e-05	0.000235	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.91e-05	0.000229	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	5.83e-05	0.000226	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AGT—dilated cardiomyopathy	5.82e-05	0.000226	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.7e-05	0.000221	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.6e-05	0.000217	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.59e-05	0.000217	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.57e-05	0.000216	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	5.57e-05	0.000216	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.56e-05	0.000215	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.5e-05	0.000213	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.4e-05	0.00021	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.33e-05	0.000207	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	5.33e-05	0.000207	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.32e-05	0.000206	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.32e-05	0.000206	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.3e-05	0.000206	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.29e-05	0.000205	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.27e-05	0.000204	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.26e-05	0.000204	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.22e-05	0.000202	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—CD36—dilated cardiomyopathy	5.19e-05	0.000201	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.96e-05	0.000192	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	4.75e-05	0.000184	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.71e-05	0.000183	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.69e-05	0.000182	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—AGT—dilated cardiomyopathy	4.68e-05	0.000181	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.64e-05	0.00018	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.63e-05	0.00018	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.62e-05	0.000179	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.61e-05	0.000179	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.59e-05	0.000178	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.57e-05	0.000177	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.56e-05	0.000177	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.55e-05	0.000176	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.54e-05	0.000176	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	4.54e-05	0.000176	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.53e-05	0.000176	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.49e-05	0.000174	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.49e-05	0.000174	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.4e-05	0.00017	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	4.27e-05	0.000166	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	4.19e-05	0.000163	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	4.13e-05	0.00016	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.12e-05	0.00016	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.11e-05	0.000159	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	4.09e-05	0.000159	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	4.05e-05	0.000157	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—RAF1—dilated cardiomyopathy	4.04e-05	0.000157	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	4.01e-05	0.000155	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	3.94e-05	0.000153	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	3.93e-05	0.000153	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	3.92e-05	0.000152	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	3.91e-05	0.000152	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	3.87e-05	0.00015	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	3.87e-05	0.00015	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.66e-05	0.000142	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	3.38e-05	0.000131	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CD36—dilated cardiomyopathy	3.3e-05	0.000128	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.23e-05	0.000125	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	3.19e-05	0.000124	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.18e-05	0.000123	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.17e-05	0.000123	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.16e-05	0.000123	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	3.15e-05	0.000122	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.15e-05	0.000122	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.12e-05	0.000121	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	3.11e-05	0.00012	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.97e-05	0.000115	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	2.93e-05	0.000114	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.8e-05	0.000108	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.78e-05	0.000108	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—EGFR—dilated cardiomyopathy	2.77e-05	0.000107	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.74e-05	0.000106	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.73e-05	0.000106	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.72e-05	0.000106	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	2.71e-05	0.000105	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	2.7e-05	0.000105	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.69e-05	0.000104	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	2.65e-05	0.000103	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	2.63e-05	0.000102	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	2.37e-05	9.19e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	2.16e-05	8.38e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.91e-05	7.4e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.88e-05	7.28e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.87e-05	7.26e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.87e-05	7.24e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.86e-05	7.22e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.84e-05	7.15e-05	CbGpPWpGaD
